The G(M2) activator protein is an essential component for the degradat
ion of G(M2) ganglioside by hexosaminidase A in vivo. Mutations in the
human gene coding for the G(M2) activator protein cause the AB varian
t of G(M2)-gangliosidosis, a condition that is clinically indistinguis
hable from Tay-Sachs disease. To understand better factors affecting t
he expression of the G(M2) activator protein gene (Gm2a) in mouse tiss
ues, we have determined its exon-intron organization and analyzed its
promoter region. Gm2a is about 14 kb, has four exons, and the 5' flank
ing region contains a CAAT box, Sp1 binding sites, AP-1, AP-2 sites, a
nd a pair of IRE sites. A 1.2-kb fragment upstream from the initiation
codon was shown to have promoter activity in NIH 3T3 cells. Similarit
ies between the elements present in Gm2a and Hexa promoters might in p
art explain their similar expression patterns in mouse tissues. The di
fferent levels of G(M2) activator protein mRNA in liver, kidney, brain
, and testis are not owing to the use of different transcription start
sites, because a single start site was found 50 bp upstream from the
initiation codon in each these tissues. Northern blot analysis demonst
rated variation in the G(M2) activator protein mRNA expression during
mouse development. Gm2a was mapped to Chromosome (Chr) 11, where it co
-segregated with Csfgm.